Isofol Medical AB (publ) (FRA:5IU)

Germany flag Germany · Delayed Price · Currency is EUR
0.0540
+0.0017 (3.25%)
At close: Jan 5, 2026
-75.51%
Market Cap18.82M
Revenue (ttm)n/a
Net Income (ttm)-4.93M
Shares Outn/a
EPS (ttm)-0.03
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volumen/a
Average Volumen/a
Open0.0540
Previous Close0.0523
Day's Range0.0540 - 0.0540
52-Week Range0.0465 - 0.2205
Betan/a
RSI46.06
Earnings DateFeb 18, 2026

About Isofol Medical AB

Isofol Medical AB (publ) operates as a clinical stage biotech company. The company develops arfolitixorin, which is in phase Ib/II clinical trial for the treatment of metastatic colorectal cancer. Isofol Medical AB (publ) was incorporated in 2008 and is based in Gothenburg, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2008
Employees 5
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 5IU
Full Company Profile

Financial Performance

Financial numbers in SEK Financial Statements

News

There is no news available yet.